- Breaking News
- |
- Entertainment
- |
- Sports
- |
- Business
- |
- Politics
- |
- Science
- |
- Technology
- |
- Odd News
- |
- Health
- |
- Law
Chronic Pain
NOT JUST FOR DEPRESSION: The Food and Drug Administration is raising questions about the antidepressant Cymbalta, as Eli Lilly & Co.

WASHINGTON - Federal health scientists are questioning whether the antidepressant Cymbalta is safe and effective enough to be approved for use against chronic pain.
LOS ANGELES - A doctor for Anna Nicole Smith says the late Playboy model had chronic pain syndrome that was a challenge to treat because she was addicted to prescription drugs.

LONDON - American soldiers in Iraq and Afghanistan were more likely to be medically evacuated for health problems such as a bad back than for combat injuries, a new study says.

NORTH CHICAGO, Ill. - Abbott Laboratories said Thursday it is buying a potential chronic pain drug from PanGenetics BV for as much as $190 million.